Antimicrobial peptides with therapeutic potential from skin secretions of the Marsabit clawed frog Xenopus borealis (Pipidae)

Comparative Biochemistry and Physiology - C Toxicology and Pharmacology

Volumn 152, Issue 4, 2010, Pages 467-472

  Mechkarska, Milena ^a   Ahmed, Eman ^a   Coquet, Laurent ^b   Leprince, Jérôme ^b   Jouenne, Thierry ^b   Vaudry, Hubert ^b   King, Jay D ^c   Conlon, J Michael ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITÉ DE ROUEN   (France)

^c Rare Species Conservatory Foundation   (United States)

Author keywords

Antimicrobial peptide; Frog skin; Magainin; PGLa; Procaerulein; Proxenopsin

Indexed keywords

MAGAININ B1; MAGAININ B2; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN CPF B1; PROTEIN CPF B2; PROTEIN CPF B3; PROTEIN CPF B4; PROTEIN PGLA B1; PROTEIN PGLA B2; PROTEIN XPF B1; PROTEIN XPF B2; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; AMINO ACID SEQUENCE; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; ESCHERICHIA COLI; FEMALE; HEMOLYSIS; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; SKIN SECRETION; STAPHYLOCOCCUS AUREUS; XENOPUS; XENOPUS BOREALIS;

ACINETOBACTER BAUMANNII; ANURA; CANDIDA ALBICANS; ESCHERICHIA COLI; PIPIDAE; STAPHYLOCOCCUS AUREUS; XENOPUS (GENUS); XENOPUS BOREALIS; XENOPUS LAEVIS;

EID: 77956342622     PISSN: 15320456     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpc.2010.07.007     Document Type: Article

References (41)

1. Ali M.F., Soto A., Knoop F.C., Conlon J.M. Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae). Biochim. Biophys. Acta 2001, 1550:81-89.
2. Bessalle R., Haas H., Goria A., Shalit I., Fridkin M. Augmentation of the antibacterial activity of magainin by positive-charge chain extension. Antimicrob. Agents Chemother. 1992, 36:313-317.
3. Bowling F.L., Jude E.B., Boulton A.J. MRSA and diabetic foot wounds: contaminating or infecting organisms?. Curr. Diab. Rep. 2009, 9:440-444.
4. Chambers H.F., Deleo F.R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 2009, 7:629-641.
5. Clinical Laboratory and Standards Institute, 2008a. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard M07-A8. CLSI, Wayne, PA.
6. Clinical Laboratory and Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast. Approved Standard M27-A3. CLS1, Wayne, PA.
7. Conlon J.M., Al-Ghaferi N., Abraham B., Leprince J. Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Methods 2007, 42:349-357.
8. Conlon J.M., Ahmed E., Condamine E. Antimicrobial properties of brevinin-2-related peptide and its analogs: efficacy against multidrug-resistant Acinetobacter baumannii. Chem. Biol. Drug Des. 2009, 74:488-493.
9. Conlon J.M., Al-Ghaferi N., Ahmed E., Meetani M.A., Leprince J., Nielsen P.F. Orthologs of magainin, PGLa, procaerulein-derived, and proxenopsin-derived peptides from skin secretions of the octoploid frog Xenopus amieti (Pipidae). Peptides 2010, 31:989-994.
10. Cooke F.J., Brown N.M. Community-associated methicillin-resistant Staphylococcus aureus infections. Br. Med. Bull. 2010, 94:215-227.
11. Dathe M., Nikolenko H., Meyer J., Beyermann M., Bienert M. Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS Lett. 2001, 501:146-150.
12. de Sa R.O., Hillis D.M. Phylogenetic relationships of the pipid frogs Xenopus and Silurana: an integration of ribosomal DNA and morphology. Mol. Biol. Evol. 1990, 7:365-376.
13. Deleo F.R., Otto M., Kreiswirth B.N., Chambers H.F. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 2010, 375:1557-1568.
14. Dijkshoorn L., Nemec A., Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 2007, 5:939-951.
15. Evans B.J., Kelley D.B., Tinsley R.C., Melnick D.J., Cannatella D.C. A mitochondrial DNA phylogeny of African clawed frogs: phylogeography and implications for polyploid evolution. Mol. Phylogenet. Evol. 2004, 33:197-213.
16. Frost D.R. Amphibian Species of the World: an Online Reference. Version 5.4 2010, American Museum of Natural History, New York, USA, Electronic database accessible at http://research.amnh.org/herpetology/amphibia/index.php.
17. Garau J., Bouza E., Chastre J., Gudiol F., Harbarth S. Management of methicillin-resistant Staphylococcus aureus infections. Clin. Microbiol. Infect. 2009, 15:125-136.
18. Geria A.N., Schwartz R.A. Impetigo update: new challenges in the era of methicillin resistance. Cutis 2010, 85:65-70.
19. a and the caerulein and xenopsin precursors from Xenopus laevis. J. Biol. Chem. 1986, 261:5341-5349.
20. Giovannini M.G., Poulter L., Gibson B.W., Williams D.H. Biosynthesis and degradation of peptides derived from Xenopus laevis prohormones. Biochem. J. 1987, 243:113-120.
21. Gootz T.D., Marra A. Acinetobacter baumannii: an emerging multidrug-resistant threat. Expert Rev. Anti Infect. Ther. 2008, 6:309-325.
22. Hunt L.T., Barker W.C. Relationship of promagainin to three other prohormones from the skin of Xenopus laevis: a different perspective. FEBS Lett. 1988, 233:282-288.
23. James S., Gibbs B.F., Toney K., Bennett H.P. Purification of antimicrobial peptides from an extract of the skin of Xenopus laevis using heparin-affinity HPLC: characterization by ion-spray mass spectrometry. Anal. Biochem. 1994, 217:84-90.
24. Karageorgopoulos D.E., Falagas M.E. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect. Dis. 2008, 8:751-762.
25. Kobel H.R., Du Pasquier L. Genetics of Xenopus laevis. Methods Cell Biol. 1991, 36:9-34.
26. Kuchler K., Kreil G., Sures I. The genes for the frog skin peptides GLa, xenopsin, levitide and caerulein contain a homologous export exon encoding a signal sequence and part of an amphiphilic peptide. Eur. J. Biochem. 1989, 179:281-285.
27. Livermore D.M. Has the era of untreatable infections arrived?. J. Antimicrob. Chemother. 2009, 64(Suppl. 1):i29-i36.
28. Norrby S.R., Nord C.E., Finch R. Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect. Dis. 2005, 5:115-119.
29. Pál T., Abraham B., Sonnevend Á., Jumaa P., Conlon J.M. Brevinin-1BYa: a naturally occurring peptide from frog skin with broad spectrum anti-bacterial and anti-fungal properties. Int. J. Antimicrob. Agents 2006, 27:525-529.
30. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 2008, 21:538-582.
31. Powers J.P., Hancock R.E. The relationship between peptide structure and antibacterial activity. Peptides 2003, 24:1681-1691.
32. Richter K., Egger R., Kreil G. Sequence of preprocaerulein cDNAs cloned from skin of Xenopus laevis. A small family of precursors containing one, three, or four copies of the final product. J. Biol. Chem. 1986, 261:3676-3680.
33. Rinaldi A.C. Antimicrobial peptides from amphibian skin: an expanding scenario. Curr. Opin. Chem. Biol. 2002, 6:799-804.
34. Schiffer M., Edmundson A.B. Use of helical wheels to represent the structures of proteins and to identify segments with helical potential. Biophys. J. 1967, 7:121-135.
35. Sebeny P.J., Riddle M.S., Petersen K. Acinetobacter baumannii skin and soft-tissue infection associated with war trauma. Clin. Infect. Dis. 2008, 47:444-449.
36. Soravia E., Martini G., Zasloff M. Antimicrobial properties of peptides from Xenopus granular gland secretions. FEBS Lett. 1988, 228:337-340.
37. Tinsley R., Measey J., Howell K., Lötters S. Xenopus borealis. IUCN Red List of Threatened Species. Version 2010.1 2004, Electronic database accessible at www.iucnredlist.org.
38. Tymowska J., Fischberg M. A comparison of the karyotype, constitutive heterochromatin, and nucleolar organizer regions of the new tetraploid species Xenopus epitropicalis Fischberg and Picard with those of Xenopus tropicalis Gray (Anura, Pipidae). Cytogenet. Cell Genet. 1982, 34:49-157.
39. Vila J., Pachón J. Therapeutic options for Acinetobacter baumannii infections. Expert Opin. Pharmacother. 2008, 9:587-599.
40. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms and partial cDNA sequence of a precursor. Proc. Natl Acad. Sci. USA 1987, 84:5449-5453.
41. Zhang M., Falla T.J. Potential therapeutic applications of host defense peptides. Methods Mol. Biol. 2010, 618:303-327.